{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:29:27Z","timestamp":1773408567284,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2009,12,17]],"date-time":"2009-12-17T00:00:00Z","timestamp":1261008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,12,17]],"date-time":"2009-12-17T00:00:00Z","timestamp":1261008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1038\/jhh.2009.97","type":"journal-article","created":{"date-parts":[[2009,12,17]],"date-time":"2009-12-17T10:19:41Z","timestamp":1261045181000},"page":"538-544","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Carotid atherosclerosis in elderly hypertensive patients: potential role of endothelin and plasma antioxidant capacity"],"prefix":"10.1038","volume":"24","author":[{"given":"A B","family":"Skalska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Grodzicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,17]]},"reference":[{"key":"BFjhh200997_CR1","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1097\/00004872-199816080-00001","volume":"16","author":"WG Haynes","year":"1998","unstructured":"Haynes WG, Webb DJ . Endothelin as a regulator of cardiovascular function in health and disease. J Hypertens 1998; 16: 1081\u20131098.","journal-title":"J Hypertens"},{"key":"BFjhh200997_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1023\/A:1011400124060","volume":"6","author":"S Taddei","year":"2001","unstructured":"Taddei S, Viridis A, Ghiadoni L, Sudano I, Magagna A, Salvetti A . Role of endothelin in the control of peripheral vascular tone in human hypertension. Heart Fail Rev 2001; 6: 277\u2013285.","journal-title":"Heart Fail Rev"},{"key":"BFjhh200997_CR3","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/FJC.0b013e31813c6cc3","volume":"50","author":"M Iglarz","year":"2007","unstructured":"Iglarz M, Clozel M . Mechanisms of ET-1-induced endothelial dysfunction. J Cardiovasc Pharmacol 2007; 50: 621\u2013628.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl 2","key":"BFjhh200997_CR4","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1097\/00005344-200000002-00013","volume":"35","author":"LV d\u2019Uscio","year":"2000","unstructured":"d\u2019Uscio LV, Barton M, Shaw S, L\u00fcscher TF . Endothelin in atherosclerosis: importance of risk factors and therapeutic implications. J Cardiovasc Pharmacol 2000; 35 (Suppl 2): S55\u2013S59.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BFjhh200997_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1748-1716.2009.01964.x","volume":"196","author":"PM Vanhoutte","year":"2009","unstructured":"Vanhoutte PM, Shimokawa H, Tang EHC, Feletou M . Endothelial dysfunction and vascular disease. Acta Physiol 2009; 196: 193\u2013222.","journal-title":"Acta Physiol"},{"key":"BFjhh200997_CR6","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/sj.bjp.0702141","volume":"125","author":"M Yoshizumi","year":"1998","unstructured":"Yoshizumi M, Kim S, Kagami S, Hamaguchi A, Tsuchiya K, Houchi H et al. Effect of endothelin-1 (1\u201331) on extracellular signal-regulated kinase and proliferation of human coronary artery smooth muscle cells. Br J Pharmacol 1998; 125: 1019\u20131027.","journal-title":"Br J Pharmacol"},{"key":"BFjhh200997_CR7","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/dmrr.689","volume":"23","author":"S Chen","year":"2007","unstructured":"Chen S, Khan ZA, Karmazyn M, Chakrabarti S . Role of endothelin-1, sodium hydrogen exchanger-1 and mitogen activated protein kinase (MAPK) activation in glucose-induced cardiomyocyte hypertrophy. Diabetes Metab Res Rev 2007; 23: 356\u2013367.","journal-title":"Diabetes Metab Res Rev"},{"key":"BFjhh200997_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11373-004-8168-6","volume":"12","author":"TH Cheng","year":"2005","unstructured":"Cheng TH, Shih NL, Chen CH, Lin H, Liu JC, Chao HH et al. Role of mitogen-activated protein kinase pathway in reactive oxygen species-mediated endothelin-1-induced beta-myosin heavy chain gene expression and cardiomyocyte hypertrophy. J Biomed Sci 2005; 12: 123\u2013133.","journal-title":"J Biomed Sci"},{"key":"BFjhh200997_CR9","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.pharmthera.2005.08.012","volume":"110","author":"S Motte","year":"2006","unstructured":"Motte S, McEntee K, Naeije R . Endothelin receptor antagonists. Pharmacol Ther 2006; 110: 386\u2013414.","journal-title":"Pharmacol Ther"},{"key":"BFjhh200997_CR10","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1161\/01.ATV.0000012804.63152.60","volume":"2","author":"F B\u00f6hm","year":"2002","unstructured":"B\u00f6hm F, Ahlborg G, Johansson BL, Hansson LO, Pernow J . Combined endothelin receptor blockade evokes enhanced vasodilatation in patients with atherosclerosis. Arterioscler Thromb Vasc Biol 2002; 2: 674\u2013679.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFjhh200997_CR11","doi-asserted-by":"publisher","first-page":"14367","DOI":"10.1073\/pnas.95.24.14367","volume":"24","author":"M Barton","year":"1998","unstructured":"Barton M, Haudenschild CC, d\u2019Uscio LV, Shaw S, M\u00fcnter K, L\u00fcscher TF . Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. Proc Natl Acad Sci USA 1998; 24: 14367\u201314372.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFjhh200997_CR12","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1161\/01.CIR.0000144462.08345.B9","volume":"110","author":"F Amiri","year":"2004","unstructured":"Amiri F, Viridis A, Neves MF, Iglarz M, Seidah NG, Touyz RM et al. Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction. Circulation 2004; 110: 2233\u20132240.","journal-title":"Circulation"},{"key":"BFjhh200997_CR13","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1161\/01.CIR.0000051459.74466.46","volume":"107","author":"L Li","year":"2003","unstructured":"Li L, Fink GD, Watts SW, Northcott CA, Galligan JJ, Pagano PJ et al. Endothelin-1 increases vascular superoxide via endothelin A-NADPH oxidase pathway in low-renin hypertension. Circulation 2003; 107: 1053\u20131058.","journal-title":"Circulation"},{"key":"BFjhh200997_CR14","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1006\/jmcc.2000.1178","volume":"32","author":"J K\u00e4hler","year":"2000","unstructured":"K\u00e4hler J, Mendel S, Weckm\u00fcller J, Orzechowski HD, Mittmann C, K\u00f6ster R et al. Oxidative stress increases synthesis of big endothelin-1 by activation of the endothelin-1 promoter. J Mol Cell Cardiol 2000; 32: 1429\u20131437.","journal-title":"J Mol Cell Cardiol"},{"key":"BFjhh200997_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00005344-200107000-00006","volume":"38","author":"J K\u00e4hler","year":"2001","unstructured":"K\u00e4hler J, Ewert A, Weckm\u00fcller J, Stobbe S, Mittmann C, K\u00f6ster R et al. Oxidative stress increases endothelin-1 synthesis in human coronary artery smooth muscle cells. J Cardiovacs Pharmacol 2001; 38: 49\u201357.","journal-title":"J Cardiovacs Pharmacol"},{"key":"BFjhh200997_CR16","doi-asserted-by":"publisher","first-page":"L1058","DOI":"10.1152\/ajplung.2001.281.5.L1058","volume":"281","author":"S Wedgwood","year":"2001","unstructured":"Wedgwood S, Dettman R, Black SM . ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species. Am J Physiol Lung Cell Mol Physiol 2001; 281: L1058\u2013L1067.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"BFjhh200997_CR17","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.clinbiochem.2008.11.002","volume":"42","author":"A Skalska","year":"2009","unstructured":"Skalska A, Pietrzycka A, St\u00eapniewski M . Correlation of endothelin 1 plasma levels with plasma antioxidant capacity in elderly patients treated for hypertension. Clin Biochem 2009; 42: 358\u2013364 (doi: 10.1016\/j.clinbiochem.2008.11.002).","journal-title":"Clin Biochem"},{"key":"BFjhh200997_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1006\/abio.1996.0292","volume":"239","author":"IFF Benzie","year":"1996","unstructured":"Benzie IFF, Strain JJ . The ferric reducing ability of plasma (FRAP) as a measure of \u2018antioxidant power\u2019: the FRAP assay. Anal Biochem 1996; 239: 70\u201376.","journal-title":"Anal Biochem"},{"key":"BFjhh200997_CR19","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Int Med 1999; 130: 461\u2013470.","journal-title":"Ann Int Med"},{"key":"BFjhh200997_CR20","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jns.2006.04.007","volume":"247","author":"E Katona","year":"2006","unstructured":"Katona E, Settakis G, Varga Z, Paragh G, Bereczki D, F\u00fclesdi B et al. Target-organ damage in adolescent hypertension. Analysis of potential influencing factors, especially nitric oxide and endothelin-1. J Neurol Sci 2006; 247: 138\u2013143.","journal-title":"J Neurol Sci"},{"key":"BFjhh200997_CR21","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.1210\/jc.2003-031867","volume":"89","author":"F Orio Jr","year":"2004","unstructured":"Orio Jr F, Palomba S, Cascella T, De Simone B, Di Biase S, Russo T et al. Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome. J Clin Endocrinol Metab 2004; 89: 4588\u20134593.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFjhh200997_CR22","first-page":"27","volume":"108","author":"IN Migdalis","year":"2000","unstructured":"Migdalis IN, Kalogeropoulou K, Iiopoulou V, Varvarigos N, Karmaniolas KD, Mortzos G et al. Progression of carotid atherosclerosis and the role of endothelin in diabetic patients. Res Commun Mol Pathol Pharmacol 2000; 108: 27\u201337.","journal-title":"Res Commun Mol Pathol Pharmacol"},{"key":"BFjhh200997_CR23","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/000331970205300305","volume":"53","author":"K Kalogeropoulou","year":"2002","unstructured":"Kalogeropoulou K, Mortzos G, Migdalis IN, Velentzas C, Mikhailidis DP, Georgiadis E et al. Carotid atherosclerosis in type 2 diabetes mellitus: potential role of endothelin-1, lipoperoxides, and prostacyclin. Angiology 2002; 53: 279\u2013285.","journal-title":"Angiology"},{"key":"BFjhh200997_CR24","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1291\/hypres.24.663","volume":"24","author":"S Minami","year":"2001","unstructured":"Minami S, Yamano S, Yamamoto Y, Sasaki R, Nakashima T, Takaoka M et al. Associations of plasma endothelin concentration with carotid atherosclerosis and asymptomatic cerebrovascular lesions in patients with essential hypertension. Hypertens Res 2001; 24: 663\u2013670.","journal-title":"Hypertens Res"},{"key":"BFjhh200997_CR25","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1161\/hc3301.094742","volume":"104","author":"Ch Ihling","year":"2001","unstructured":"Ihling Ch, Szombathy T, Bohrmann B, Brockhaus M, Schaefer HE, Loeffler BM . Coexpression of endothelin-converting enzyme-1 and endothelin-1 in different stages of human atherosclerosis. Circulation 2001; 104: 864\u2013869.","journal-title":"Circulation"},{"key":"BFjhh200997_CR26","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/S0006-2952(02)01349-7","volume":"64","author":"M Kyaw","year":"2002","unstructured":"Kyaw M, Yoshizumi M, Tsuchiya K, Kirima K, Suzaki Y, Abe S et al. Antioxidant inhibit endothelin-1 (1\u201331)-induced proliferation of vascular smooth muscle cells via the inhibition of mitogen-activated protein (MAP) kinase and activator protein-1 (AP-1). Biochem Pharmacol 2002; 64: 1521\u20131531.","journal-title":"Biochem Pharmacol"},{"key":"BFjhh200997_CR27","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1006\/bbrc.2000.2354","volume":"269","author":"N Duerrschmidt","year":"2000","unstructured":"Duerrschmidt N, Wippich N, Goettsch W, Broemme HJ, Morawietz H . Endothelin-1 induces NAD(P)H oxidase in human endothelial cells. Biochem Biophys Res Commun 2000; 269: 713\u2013717.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFjhh200997_CR28","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.atherosclerosis.2006.02.018","volume":"190","author":"F B\u00f6hm","year":"2007","unstructured":"B\u00f6hm F, Settergren M, Pernow J . Vitamin C blocks vascular dysfunction and release of interleukin-6 induced by endothelin-1 in humans in vivo. Atherosclerosis 2007; 190: 408\u2013415.","journal-title":"Atherosclerosis"},{"key":"BFjhh200997_CR29","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1152\/physrev.00047.2003","volume":"84","author":"R Stocker","year":"2004","unstructured":"Stocker R, Keaney Jr JF . Role of oxidative modification in atherosclerosis. Physiol Rev 2004; 84: 1381\u20131478.","journal-title":"Physiol Rev"},{"key":"BFjhh200997_CR30","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1161\/hy09t1.094005","volume":"38","author":"X Chen","year":"2001","unstructured":"Chen X, Touyz RM, Park JB, Schiffrin EL . Antioxidant effects of vitamin C and E are associated with altered activation of vascular NADP oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 2001; 38: 606\u2013611.","journal-title":"Hypertension"},{"key":"BFjhh200997_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2008.02.024","volume":"392","author":"G Lippi","year":"2008","unstructured":"Lippi G, Montagnana M, Franchini M, Favaloro EJ, Targher G . The paradoxical relationship between serum uric acid and cardiovascular disease. Clin Chim Acta 2008; 392: 1\u20137.","journal-title":"Clin Chim Acta"},{"key":"BFjhh200997_CR32","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMra0800885","volume":"359","author":"DI Feig","year":"2008","unstructured":"Feig DI, Kang DH, Johnson R . Uric acid and cardiovascular risk. N Engl J Med 2008; 359: 1811\u20131821.","journal-title":"N Engl J Med"},{"key":"BFjhh200997_CR33","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1161\/01.STR.23.12.1752","volume":"23","author":"DH O\u2019Leary","year":"1992","unstructured":"O\u2019Leary DH, Polak JF, Kronmal RA, Kittner SJ, Bond MG, Wolfson SK et al. Distribution and correlates of sonographically detected carotid disease in the Cardiovascular Health Study. The CHS Collaborative Research Group. Stroke 1992; 23: 1752\u20131760.","journal-title":"Stroke"},{"key":"BFjhh200997_CR34","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1291\/hypres.30.1159","volume":"30","author":"R Rodrigo","year":"2007","unstructured":"Rodrigo R, Prat H, Passalacqua W, Araya J, Guichard C, B\u00e4chler JP . Relationship between oxidative stress and essential hypertension. Hypertens Res 2007; 30: 1159\u20131167.","journal-title":"Hypertens Res"},{"key":"BFjhh200997_CR35","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/S0735-1097(01)01676-X","volume":"38","author":"BM McQuillan","year":"2001","unstructured":"McQuillan BM, Hung J, Beilby JP, Nidorf M, Thompson PL . Antioxidant vitamins and the risk of carotid atherosclerosis. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS). J Am Coll Cardiol 2001; 38: 1788\u20131794.","journal-title":"J Am Coll Cardiol"},{"key":"BFjhh200997_CR36","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/ajcn\/74.3.402","volume":"74","author":"CR Gale","year":"2001","unstructured":"Gale CR, Ashurst HE, Powers HJ, Martyn ChN . Antioxidant vitamin status and carotid atherosclerosis in the elderly. Am J Clin Nutr 2001; 74: 402\u2013408.","journal-title":"Am J Clin Nutr"},{"key":"BFjhh200997_CR37","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1161\/01.CIR.92.8.2142","volume":"92","author":"SB Kritchevsky","year":"1995","unstructured":"Kritchevsky SB, Shimakawa T, Tell GS, Dennis B, Carpenter M, Eckfeldt JH et al. Dietary antioxidants and carotid artery wall thickness: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 1995; 92: 2142\u20132150.","journal-title":"Circulation"},{"key":"BFjhh200997_CR38","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/ajcn\/65.1.121","volume":"65","author":"C Bonithon-Kopp","year":"1997","unstructured":"Bonithon-Kopp C, Coudray C, Berr C, Touboul PJ, F\u00e8ve JM, Favier A et al. Combined effects of lipid peroxidation and antioxidant status on carotid atherosclerosis in a population aged 59\u201371 years: the Etude sur le Vieillisement Arteriel (EVA) study. Am J Clin Nutr 1997; 65: 121\u2013127.","journal-title":"Am J Clin Nutr"},{"key":"BFjhh200997_CR39","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000164691","volume":"53","author":"G Riccioni","year":"2008","unstructured":"Riccioni G, Bucciarelli T, D\u2019Orazio N, Palumbo N, Di Ilio E, Corradi F et al. Plasma antioxidants and asymptomatic carotid atherosclerotic disease. Ann Nutr Metabol 2008; 53: 86\u201390.","journal-title":"Ann Nutr Metabol"},{"key":"BFjhh200997_CR40","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1203\/PDR.0b013e318142581a","volume":"62","author":"B Suys","year":"2007","unstructured":"Suys B, de Beeck LO, Rooman R, Kransfeld S, Heuten H, Goovaerts I et al. Impact of oxidative stress on the endothelial dysfunction of children and adolescents with type I diabetes mellitus: protection by superoxide dismutase? Pediatr Res 2007; 62: 456\u2013461.","journal-title":"Pediatr Res"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/jhh200997.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jhh200997","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jhh200997.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T17:22:03Z","timestamp":1647537723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhh200997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,17]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["BFjhh200997"],"URL":"https:\/\/doi.org\/10.1038\/jhh.2009.97","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,17]]},"assertion":[{"value":"17 August 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}